FDA Inspection 1022656 — Chongqing Carelife Pharmaceutical Co., Ltd.
The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on July 26, 2017 in Chongqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 26, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Chongqing (China)